Avantor Inc. (AVTR) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Avantor Inc. (AVTR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

21.71

-0.31 (-1.41%)

At close: Jan 14, 2025, 3:59 PM

21.72

0.02%

After-hours Jan 14, 2025, 07:00 PM EST

undefined% (undefined)

Bid	20
Market Cap	14.78B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.45
PE Ratio (ttm)	48.26
Forward PE	n/a
Analyst	Buy

Ask	22.48
Volume	3,644,876
Avg. Volume (20D)	5,775,055
Open	21.96
Previous Close	22.02
Day's Range	21.68 - 22.20
52-Week Range	19.59 - 28.00
Beta	undefined

About AVTR

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography r...

[Show more]

Industry Chemicals - Specialty

Sector Basic Materials

IPO Date May 17, 2019

Employees 14,500

Stock Exchange NYSE

Ticker Symbol AVTR

Website https://www.avantorsciences.com

Analyst Forecast

According to 13 analyst ratings, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $27.5, which is an increase of 26.64% from the latest price.

Buy 84.62%

Hold 15.38%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Avantor Inc. is scheduled to release its earnings on Feb 7, 2025, before market opens.
Analysts project revenue of $1.72B, reflecting a -0.16% YoY shrinking and earnings per share of 0.26, making a 4.00% increase YoY.

Why Price Moved

2 months ago · Source

+0.94%

Avantor shares are trading higher. Baird maintaine... Unlock content with Pro Subscription

2 months ago · Source

-3.61%

Avantor shares are trading lower after the company reported worse-than-expected Q3 revenue results.

News

2 days ago · zacks.com

MD vs. AVTR: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value inve...

2 weeks ago · zacks.com

MD vs. AVTR: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those ...

4 weeks ago · seekingalpha.com

Avantor: Durable FCF Generator Trading For Cheap

Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansi...

1 month ago · zacks.com

MD or AVTR: Which Is the Better Value Stock Right Now?

1 month ago · businesswire.com

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (N...

2 months ago · zacks.com

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down

Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.

2 months ago · seekingalpha.com

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript

Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent ...

2 months ago · zacks.com

Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street esti...

2 months ago · zacks.com

Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.

2 months ago · zacks.com

AVTR Stock Flat Following the Close of Divestiture Deal With Audax

Avantor closes its deal with Audax to divest its clinical services business.

2 months ago · businesswire.com

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with t...